|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:bfsLayer
|
3
|
|
gptkbp:bfsParent
|
gptkb:Tandem_Diabetes
|
|
gptkbp:acquisition
|
gptkb:Apex_Medical_Technologies
|
|
gptkbp:awards
|
Best Places to Work
|
|
gptkbp:ceo
|
gptkb:Shacey_Petrovic
|
|
gptkbp:clinical_trial
|
gptkb:battle
|
|
gptkbp:community_engagement
|
gptkb:battle
|
|
gptkbp:competitors
|
gptkb:Tandem_Diabetes_Care
gptkb:Roche
gptkb:Medtronic
|
|
gptkbp:customer_base
|
Diabetes patients
|
|
gptkbp:customer_support
|
24/7 support
|
|
gptkbp:employees
|
over 1,000
|
|
gptkbp:features
|
User-friendly interface
Real-time data sharing
Continuous improvement initiatives
Patient education programs
Water-resistant design
Remote monitoring capabilities
User feedback integration
Clinical support services
Long-lasting battery life
Comprehensive training resources
Alerts and reminders
Automated insulin delivery
Continuous glucose monitoring integration
Customizable insulin delivery settings
Discreet and portable design
Easy pod insertion
Flexible dosing schedule
Insurance coverage assistance
Multiple dosing options
Smartphone app connectivity
Tubeless insulin delivery
|
|
gptkbp:financial_performance
|
Quarterly and annual reports available
|
|
gptkbp:focus
|
Diabetes management
|
|
gptkbp:founded
|
gptkb:2000
|
|
gptkbp:founder
|
gptkb:Duane_De_Sisto
|
|
gptkbp:global_presence
|
gptkb:battle
|
|
gptkbp:headquarters
|
gptkb:Acton,_Massachusetts
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Insulet Corporation
|
|
gptkbp:industry
|
gptkb:hospital
|
|
gptkbp:invention
|
Multiple patents in insulin delivery
|
|
gptkbp:investment
|
gptkb:battle
Institutional and retail investors
|
|
gptkbp:market
|
gptkb:Omnipod_5
|
|
gptkbp:market_cap
|
$8.5 billion (2023)
|
|
gptkbp:mission
|
To improve the lives of people with diabetes.
|
|
gptkbp:partnership
|
gptkb:Abbott_Laboratories
gptkb:Dexcom
University collaborations
|
|
gptkbp:products
|
gptkb:Omnipod_Insulin_Management_System
|
|
gptkbp:regulatory_compliance
|
FDA approved
|
|
gptkbp:research_and_development
|
gptkb:battle
|
|
gptkbp:revenue
|
$1.1 billion (2022)
|
|
gptkbp:service_area
|
Worldwide
|
|
gptkbp:social_media
|
Active on multiple platforms
|
|
gptkbp:supply_chain
|
Global supply chain
|
|
gptkbp:sustainability_initiatives
|
gptkb:battle
|
|
gptkbp:symbol
|
PODD
|
|
gptkbp:technology
|
gptkb:Telecommunications_company
|
|
gptkbp:traded_on
|
gptkb:NASDAQ
|
|
gptkbp:training
|
gptkb:battle
|
|
gptkbp:type
|
gptkb:football_club
|
|
gptkbp:vision
|
To be the leader in insulin delivery.
|
|
gptkbp:website
|
www.insulet.com
|